The role of humoral autoimmunity in gastrointestinal neuromuscular diseases

Progress in Neurobiology

Volumn 87, Issue 1, 2009, Pages 10-20

  Hubball, Andrew ^a   Martin, Joanne E ^a   Lang, Bethan ^b   De Giorgio, Roberto ^c   Knowles, Charles H ^a  

^a Centre for Academic Surgery   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Anti neuronal autoantibodies; Enteric myopathy; Enteric neuropathy; Humoral autoimmunity; Intestinal pseudo obstruction

Indexed keywords

ANTIBODY; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; ION CHANNEL;

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CHAGAS DISEASE; CONNECTIVE TISSUE DISEASE; ESOPHAGUS ACHALASIA; GASTROINTESTINAL DISEASE; HIRSCHSPRUNG DISEASE; HUMAN; HUMORAL IMMUNITY; IMMUNE MEDIATED INJURY; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL CELL OF CAJAL; INTESTINE PSEUDOOBSTRUCTION; MEMBRANE BINDING; MYASTHENIA GRAVIS; NEUROMUSCULAR DISEASE; NONHUMAN; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; REVIEW;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; GASTROINTESTINAL DISEASES; HUMANS; NEUROMUSCULAR DISEASES;

EID: 58149520299     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2008.09.011     Document Type: Review

References (140)

1. Adams R.D., and Victor M. Myasthenia gravis and episodic forms of muscular weakness. In: Lamsback W.J., and Navrozov M. (Eds). Principles of Neurology (1993), McGraw-Hill, New York 1252-1270
2. Aggestrup S., Uddman R., Sundler F., Fahrenkrug J., Hakanson R., Sorensen H.R., and Hambraeus G. Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology 84 (1983) 924-927
3. Akesson A., Wollheim F.A., Thysell H., Gustafson T., Forsberg L., Pahlm O., Wollmer P., and Akesson B. Visceral improvement following combined plasmapheresis and immunosuppressive drug therapy in progressive systemic sclerosis. Scand. J. Rheumatol. 17 (1988) 313-323
4. Almon R.R., Andrew C.G., and Appel S.H. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science 186 (1974) 55-57
5. Altermatt H.J., Rodriguez M., Scheithauer B.W., and Lennon V.A. Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells. Lab. Invest. 65 (1991) 412-420
6. Barbara G., Stanghellini V., De Giorgio R., Cremon C., Cottrell G.S., Santini D., Pasquinelli G., Morselli-Labate A.M., Grady E.F., Bunnett N.W., Collins S.M., and Corinaldesi R. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126 (2004) 693-702
7. Barbara G., Vallance B.A., and Collins S.M. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 113 (1997) 1224-1232
8. Battle W.M., Snape Jr. W.J., Wright S., Sullivan M.A., Cohen S., Meyers A., and Tuthill R. Abnormal colonic motility in progressive systemic sclerosis. Ann. Intern. Med. 94 (1981) 749-752
9. Bell Jr. C.E., Seetharam S., and McDaniel R.C. Endodermally-derived and neural crest-derived differentiation antigens expressed by a human lung tumor. J. Immunol. 116 (1976) 1236-1243
10. Blaes F., Beeson D., Plested P., Lang B., and Vincent A. IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor. Ann. Neurol. 47 (2000) 504-510
11. Boeckxstaens G.E. Novel mechanism for impaired nitrergic relaxation in achalasia. Gut 55 (2006) 304-305
12. Bruley des Varannes S., Chevalier J., Pimont S., Le Neel J.C., Klotz M., Schafer K.H., Galmiche J.P., and Neunlist M. Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus. Gut 55 (2006) 319-326
13. Castell D.O. Achalasia and diffuse esophageal spasm. Arch. Intern. Med. 136 (1976) 571-579
14. Cellek S., Foxwell N.A., and Moncada S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 52 (2003) 2353-2362
15. Chadwick V.S., Chen W., Shu D., Paulus B., Bethwaite P., Tie A., and Wilson I. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122 (2002) 1778-1783
16. Chagas C. Nova tripanosomiaze humana. Mem. Inst. Oswaldo. Cruz. 1 (1909) 159-218
17. Chan K.H., Lachance D.H., Harper C.M., and Lennon V.A. Frequency of seronegativity in adult-acquired generalized myasthenia gravis. Muscle Nerve 36 (2007) 651-658
18. Chandrasekharan B., and Srinivasan S. Diabetes and the enteric nervous system. Neurogastroenterol. Motil. 19 (2007) 951-960
19. Chinn J.S., and Schuffler M.D. Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology 95 (1988) 1279-1286
20. Clark S.B., Rice T.W., Tubbs R.R., Richter J.E., and Goldblum J.R. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am. J. Surg. Pathol. 24 (2000) 1153-1158
21. Cohen S., Fisher R., Lipshutz W., Turner R., Myers A., and Schumacher R. The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease. J. Clin. Invest. 51 (1972) 2663-2668
22. Collins S.M. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 111 (1996) 1683-1699
23. da Silveira A.B., D'Avila Reis D., de Oliveira E.C., Neto S.G., Luquetti A.O., Poole D., Correa-Oliveira R., and Furness J.B. Neurochemical coding of the enteric nervous system in chagasic patients with megacolon. Dig. Dis. Sci. 52 (2007) 2877-2883
24. Dau P.C., Kahaleh M.B., and Sagebiel R.W. Plasmapheresis and immunosuppressive drug therapy in scleroderma. Arthritis. Rheum. 24 (1981) 1128-1136
25. De Giorgio R., Barbara G., Stanghellini V., De Ponti F., Salvioli B., Tonini M., Velio P., Bassotti G., and Corinaldesi R. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am. J. Gastroenterol. 97 (2002) 2454-2459
26. De Giorgio R., Bovara M., Barbara G., Canossa M., Sarnelli G., De Ponti F., Stanghellini V., Tonini M., Cappello S., Pagnotta E., Nobile-Orazio E., and Corinaldesi R. Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility. Gastroenterology 125 (2003) 70-79
27. De Giorgio R., Di Simone M.P., Stanghellini V., Barbara G., Tonini M., Salvioli B., Mattioli S., and Corinaldesi R. Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia. Am. J. Gastroenterol. 94 (1999) 2357-2362
28. De Giorgio R., Sarnelli G., Corinaldesi R., and Stanghellini V. Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut 53 (2004) 1549-1552
29. de Scheerder I.K., de Buyzere M.L., Delanghe J.R., Clement D.L., and Wieme R.J. Anti-myosin humoral immune response following cardiac injury. Autoimmunity 4 (1989) 51-58
30. Di Lorenzo C. Pseudo-obstruction: current approaches. Gastroenterology 116 (1999) 980-987
31. Drachman D.B., Angus C.W., Adams R.N., Michelson J.D., and Hoffman G.J. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N. Engl. J. Med. 298 (1978) 1116-1122
32. Dudley H.A., Sinclair I.S., Mc L.I., Mc N.T., and Newsam J.E. Intestinal pseudo-obstruction. J. R. Coll. Surg. Edinb. 3 (1958) 206-217
33. Eaker E.Y., Kuldau J.G., Verne G.N., Ross S.O., and Sallustio J.E. Myenteric neuronal antibodies in scleroderma: passive transfer evokes alterations in intestinal myoelectric activity in a rat model. J. Lab. Clin. Med. 133 (1999) 551-556
34. Engel A.G. The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis. Prog. Brain Res. 49 (1979) 423-434
35. Engel A.G., and Arahata K. The membrane attack complex of complement at the endplate in myasthenia gravis. Ann. N. Y. Acad. Sci. 505 (1987) 326-332
36. Engel A.G., Lambert E.H., and Howard F.M. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin. Proc. 52 (1977) 267-280
37. Engel A.G., Sahashi K., and Fumagalli G. The immunopathology of acquired myasthenia gravis. Ann. N. Y. Acad. Sci. 377 (1981) 158-174
38. Farrugia G. Interstitial cells of Cajal in health and disease. Neurogastroenterol. Motil. 20 Suppl. 1 (2008) 54-63
39. Ferreira-Santos R. Aperistalsis of the esophagus and colon (megaesophagus and megacolon) etiologically related to Chagas' disease. Am. J. Digest. Dis. 6 (1961) 700-726
40. Galligan J.J. Ligand-gated ion channels in the enteric nervous system. Neurogastroenterol. Motil. 14 (2002) 611-623
41. Gattuso J.M., and Kamm M.A. Clinical features of idiopathic megarectum and idiopathic megacolon. Gut 41 (1997) 93-99
42. Gerl A., Storck M., Schalhorn A., Muller-Hocker J., Jauch K.W., Schildberg F.W., and Wilmanns W. Paraneoplastic chronic intestinal pseudoobstruction as a rare complication of bronchial carcinoid. Gut 33 (1992) 1000-1003
43. Ghirardo S., Sauter B., Levy G., Fiel I.M., Schiano T., and Gondolesi G. Primary intestinal autoimmune disease as a cause of chronic intestinal pseudo-obstruction. Gut 54 (2005) 1206-1207
44. Gibbons J.C., and Sullivan J.F. Chronic idiopathic pseudo-obstructive bowel disease. Am. J. Gastroenterol. 70 (1978) 306-313
45. Gilchrist A.M., Mills J.O., and Russell C.G. Acute large-bowel pseudo-obstruction. Clin. Radiol. 36 (1985) 401-404
46. Gilchrist F.C., Bunn C., Foley P.J., Lympany P.A., Black C.M., Welsh K.I., and du Bois R.M. Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP. Genes Immun. 2 (2001) 76-81
47. Goin J.C., Leiros C.P., Borda E., and Sterin-Borda L. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications. FASEB J. 11 (1997) 77-83
48. Goin J.C., Sterin-Borda L., Bilder C.R., Varrica L.M., Iantorno G., Rios M.C., and Borda E. Functional implications of circulating muscarinic cholinergic receptor autoantibodies in chagasic patients with achalasia. Gastroenterology 117 (1999) 798-805
49. Goldblatt F., Gordon T.P., and Waterman S.A. Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 123 (2002) 1144-1150
50. Goldblum J.R., Whyte R.I., Orringer M.B., and Appelman H.D. Achalasia. A morphologic study of 42 resected specimens. Am. J. Surg. Pathol. 18 (1994) 327-337
51. Gonsalkorale W.M., Perrey C., Pravica V., Whorwell P.J., and Hutchinson I.V. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?. Gut 52 (2003) 91-93
52. Graus F., Elkon K.B., Cordon-Cardo C., and Posner J.B. Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am. J. Med. 80 (1986) 45-52
53. Haas S., Bindl L., and Fischer H.P. Autoimmune enteric leiomyositis: a rare cause of chronic intestinal pseudo-obstruction with specific morphological features. Hum. Pathol. 36 (2005) 576-580
54. Heanue T.A., and Pachnis V. Enteric nervous system development and Hirschsprung's disease: advances in genetic and stem cell studies. Nat. Rev. Neurosci. 8 (2007) 466-479
55. Hietarinta M., Ilonen J., Lassila O., and Hietaharju A. Association of HLA antigens with anti-Scl-70-antibodies and clinical manifestations of systemic sclerosis (scleroderma). Br. J. Rheumatol. 33 (1994) 323-326
56. Hirsh E.H., Brandenburg D., Hersh T., and Brooks Jr. W.S. Chronic intestinal pseudo-obstruction. J. Clin. Gastroenterol. 3 (1981) 247-254
57. Hoch W., McConville J., Helms S., Newsom-Davis J., Melms A., and Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7 (2001) 365-368
58. Hughes P., Gelsthorpe K., Doughty R.W., Rowell N.R., Rosenthal F.D., and Sneddon I.B. The association of HLA-B8 with visceral disease in systemic sclerosis. Clin. Exp. Immunol. 31 (1978) 351-356
59. Huizinga J.D. Neural injury, repair, and adaptation in the GI tract. IV. Pathophysiology of GI motility related to interstitial cells of Cajal. Am. J. Physiol. 275 (1998) G381-386
60. Keshavarzian A., Iber F.L., and Vaeth J. Gastric emptying in patients with insulin-requiring diabetes mellitus. Am. J. Gastroenterol. 82 (1987) 29-35
61. Kierszenbaum F. Chagas' disease and the autoimmunity hypothesis. Clin. Microbiol. Rev. 12 (1999) 210-223
62. Kierszenbaum F. Where do we stand on the autoimmunity hypothesis of Chagas disease?. Trends Parasitol. 21 (2005) 513-516
63. Kirchhoff L.V. Changing epidemiology and approaches to therapy for chagas disease. Curr. Infect. Dis. Rep. 5 (2003) 59-65
64. Knowles C.H. New horizons in the pathogenesis of gastrointestinal neuromuscular disease. J. Pediatr. Gastroenterol. Nutr. 45 Suppl. 2 (2007) S97-102
65. Knowles C.H., Lang B., Clover L., Scott S.M., Gotti C., Vincent A., and Martin J.E. A role for autoantibodies in some cases of acquired non-paraneoplastic gut dysmotility. Scand. J. Gastroenterol. 37 (2002) 166-170
66. Knowles C.H., and Martin J.E. Slow transit constipation: a model of human gut dysmotility. Review of possible aetiologies. Neurogastroenterol. Motil. 12 (2000) 181-196
67. Knowles C.H., Silk D.B., Darzi A., Veress B., Feakins R., Raimundo A.H., Crompton T., Browning E.C., Lindberg G., and Martin J.E. Deranged smooth muscle alpha-actin as a biomarker of intestinal pseudo-obstruction: a controlled multinational case series. Gut 53 (2004) 1583-1589
68. Knowles C.H., Veress B., Tornblom H., Wallace S., Paraskeva P., Darzi A., Martin J.E., Nyberg B., and Lindberg G. Safety and diagnostic yield of laparoscopically assisted full-thickness bowel biospy. Neurogastroenterol. Motil. (2008)
69. Koberle F. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv. Parasitol. 6 (1968) 63-116
70. Kong X.C., Barzaghi P., and Ruegg M.A. Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference. EMBO Rep. 5 (2004) 183-188
71. Lang B., Dale R.C., and Vincent A. New autoantibody mediated disorders of the central nervous system. Curr. Opin. Neurol. 16 (2003) 351-357
72. Latiano A., De Giorgio R., Volta U., Palmieri O., Zagaria C., Stanghellini V., Barbara G., Mangia A., Andriulli A., Corinaldesi R., and Annese V. HLA and enteric antineuronal antibodies in patients with achalasia. Neurogastroenterol. Motil. 18 (2006) 520-525
73. Lee H.R., Lennon V.A., Camilleri M., and Prather C.M. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am. J. Gastroenterol. 96 (2001) 373-379
74. Legge D.A., Wollaeger E.E., and Carlson H.C. Intestinal pseudo-obstruction in systemic amyloidosis. Gut 11 (1970) 764-767
75. Lennon V.A., Ermilov L.G., Szurszewski J.H., and Vernino S. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J. Clin. Invest. 111 (2003) 907-913
76. Lennon V.A., Sas D.F., Busk M.F., Scheithauer B., Malagelada J.R., Camilleri M., and Miller L.J. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology 100 (1991) 137-142
77. Lindstrom J.M., Seybold M.E., Lennon V.A., Whittingham S., and Duane D.D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 26 (1976) 1054-1059
78. Lucchinetti C.F., Kimmel D.W., and Lennon V.A. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 50 (1998) 652-657
79. Martin A., Messineo A., Lionetti P., Volta U., Stanghellini V., Barbara G., Cogliandro R., Corinaldesi R., and De Giorgio R. A case of paraneoplastic inflammatory neuropathy of the gastrointestinal tract related to an underlying neuroblastoma: successful management with immunosuppressive therapy. J. Pediatr. Gastroenterol. Nutr. 46 (2008) 457-460
80. Mascaro G., Cadario G., Bordin G., Tarditi M., Ferraris G., Monteverde A., and Castano L. Plasma exchange in the treatment of nonadvanced stages of progressive systemic sclerosis. J. Clin. Apher. 3 (1987) 219-225
81. Maselli R.A., Richman D.P., and Wollmann R.L. Inflammation at the neuromuscular junction in myasthenia gravis. Neurology 41 (1991) 1497-1504
82. Mearin F., Mourelle M., Guarner F., Salas A., Riveros-Moreno V., Moncada S., and Malagelada J.R. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur. J. Clin. Invest. 23 (1993) 724-728
83. Moses P.L., Ellis L.M., Anees M.R., Ho W., Rothstein R.I., Meddings J.B., Sharkey K.A., and Mawe G.M. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut 52 (2003) 629-636
84. Newsom-Davis J., Pinching A.J., Vincent A., and Wilson S.G. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology 28 (1978) 266-272
85. Newsom-Davis J., and Vincent A. Antibody-mediated neurological disease. Curr. Opin. Neurobiol. 1 (1991) 430-435
86. Nowak T.V., Chey W.W., Chang T.M., Weisbruch J.P., and Fouquet G. Effect of streptozotocin-induced diabetes mellitus on release of vasoactive intestinal polypeptide from rodent small intestine. Dig. Dis. Sci. 40 (1995) 828-836
87. O'Mahony L., McCarthy J., Kelly P., Hurley G., Luo F., Chen K., O'Sullivan G.C., Kiely B., Collins J.K., Shanahan F., and Quigley E.M. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128 (2005) 541-551
88. Pande R., and Leis A.A. Myasthenia gravis, thymoma, intestinal pseudo-obstruction, and neuronal nicotinic acetylcholine receptor antibody. Muscle Nerve 22 (1999) 1600-1602
89. Pardi D.S., Miller S.M., Miller D.L., Burgart L.J., Szurszewski J.H., Lennon V.A., and Farrugia G. Paraneoplastic dysmotility: loss of interstitial cells of Cajal. Am. J. Gastroenterol. 97 (2002) 1828-1833
90. Park W., and Vaezi M.F. Etiology and pathogenesis of achalasia: the current understanding. Am. J. Gastroenterol. 100 (2005) 1404-1414
91. Patrick J., and Lindstrom J. Autoimmune response to acetylcholine receptor. Science 180 (1973) 871-872
92. Phillips S.F., and Pemberton J.H. Megacolon: congenital and acquired. In: Sleisenger M.H., and Fordtran J.S. (Eds). Gastrointestinal Disease (1993), W.B. Saunders, Philadelphia 888-897
93. Preston D.M., and Lennard-Jones J.E. Severe chronic constipation of young women: 'idiopathic slow transit constipation'. Gut 27 (1986) 41-48
94. Rands A.L., Whyte J., Cox B., Hall N.D., and McHugh N.J. MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I. J. Autoimmun. 15 (2000) 451-458
95. Ribeiro A.L., Gimenez L.E., Hernandez C.C., de Carvalho A.C., Teixeira M.M., Guedes V.C., Barros M.V., Lombardi F., and Rocha M.O. Early occurrence of anti-muscarinic autoantibodies and abnormal vagal modulation in Chagas disease. Int. J. Cardiol. 117 (2007) 59-63
96. Ribeiro Jr. U., Safatle-Ribeiro A.V., Habr-Gama A., Gama-Rodrigues J.J., Sohn J., and Reynolds J.C. Effect of Chagas' disease on nitric oxide-containing neurons in severely affected and unaffected intestine. Dis. Colon Rectum. 41 (1998) 1411-1417
97. Richman D.P., Wollmann R.L., Maselli R.A., Gomez C.M., Corey A.L., Agius M.A., and Fairclough R.H. Effector mechanisms of myasthenic antibodies. Ann. N. Y. Acad. Sci. 681 (1993) 264-273
98. Riemersma S., Vincent A., Beeson D., Newland C., Hawke S., Vernet-der Garabedian B., Eymard B., and Newsom-Davis J. Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J. Clin. Invest. 98 (1996) 2358-2363
99. Rose S., Young M.A., and Reynolds J.C. Gastrointestinal manifestations of scleroderma. Gastroenterol. Clin. North. Am. 27 (1998) 563-594
100. Ruiz-de-Leon A., Mendoza J., Sevilla-Mantilla C., Fernandez A.M., Perez-de-la-Serna J., Gonzalez V.A., Rey E., Figueredo A., Diaz-Rubio M., and De-la-Concha E.G. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig. Dis. Sci. 47 (2002) 15-19
101. Ruuska T.H., Karikoski R., Smith V.V., and Milla P.J. Acquired myopathic intestinal pseudo-obstruction may be due to autoimmune enteric leiomyositis. Gastroenterology 122 (2002) 1133-1139
102. 2+ channels in isolated ganglia from the myenteric plexus. Life Sci. 77 (2005) 2489-2499
103. Schobinger-Clement S., Gerber H.A., and Stallmach T. Autoaggressive inflammation of the myenteric plexus resulting in intestinal pseudoobstruction. Am. J. Surg. Pathol. 23 (1999) 602-606
104. Schuffler M.D., Baird H.W., Fleming C.R., Bell C.E., Bouldin T.W., Malagelada J.R., McGill D.B., LeBauer S.M., Abrams M., and Love J. Intestinal pseudo-obstruction as the presenting manifestation of small-cell carcinoma of the lung. A paraneoplastic neuropathy of the gastrointestinal tract. Ann. Intern. Med. 98 (1983) 129-134
105. Schuffler M.D., and Jonak Z. Chronic idiopathic intestinal pseudo-obstruction caused by a degenerative disorder of the myenteric plexus: the use of Smith's method to define the neuropathology. Gastroenterology 82 (1982) 476-486
106. Scuderi F., Marino M., Colonna L., Mannella F., Evoli A., Provenzano C., and Bartoccioni E. Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement. Lab. Invest. 82 (2002) 1139-1146
107. Shellito P.C., and Warshaw A.L. Idiopathic intermittent gastroparesis and its surgical alleviation. Am. J. Surg. 148 (1984) 408-412
108. Sigala S., Missale G., Missale C., Villanacci V., Cestari R., Grigolato P.G., Lojacono L., and Spano P.F. Different neurotransmitter systems are involved in the development of esophageal achalasia. Life Sci. 56 (1995) 1311-1320
109. Smith V.V., Gregson N., Foggensteiner L., Neale G., and Milla P.J. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. Gastroenterology 112 (1997) 1366-1371
110. Smith V.V., Lake B.D., Kamm M.A., and Nicholls R.J. Intestinal pseudo-obstruction with deficient smooth muscle alpha-actin. Histopathology 21 (1992) 535-542
111. Smith V.V., and Milla P.J. Histological phenotypes of enteric smooth muscle disease causing functional intestinal obstruction in childhood. Histopathology 31 (1997) 112-122
112. Sodhi N., Camilleri M., Camoriano J.K., Low P.A., Fealey R.D., and Perry M.C. Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig. Dis. Sci. 34 (1989) 1937-1942
113. Spiller R.C., Jenkins D., Thornley J.P., Hebden J.M., Wright T., Skinner M., and Neal K.R. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47 (2000) 804-811
114. Stanghellini V., Camilleri M., and Malagelada J.R. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 28 (1987) 5-12
115. Stanley E.F., and Drachman D.B. Effect of myasthenic immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions. Science 200 (1978) 1285-1287
116. Sterin-Borda L., Goin J.C., Bilder C.R., Iantorno G., Hernando A.C., and Borda E. Interaction of human chagasic IgG with human colon muscarinic acetylcholine receptor: molecular and functional evidence. Gut 49 (2001) 699-705
117. Storch W.B., Eckardt V.F., Wienbeck M., Eberl T., Auer P.G., Hecker A., Junginger T., and Bosseckert H. Autoantibodies to Auerbach's plexus in achalasia. Cell. Mol. Biol. (Noisy-le-grand) 41 (1995) 1033-1038
118. Terwindt G.M., Ophoff R.A., Haan J., Sandkuijl L.A., Frants R.R., Ferrari M.D., and Dutch Migraine Genetics Research Group. Migraine, ataxia and epilepsy: a challenging spectrum of genetically determined calcium channelopathies. Eur. J. Hum. Genet. 6 (1998) 297-307
119. Tornblom H., Abrahamsson H., Barbara G., Hellstrom P.M., Lindberg G., Nyhlin H., Ohlsson B., Simren M., Sjolund K., Sjovall H., Schmidt P.T., and Ohman L. Inflammation as a cause of functional bowel disorders. Scand. J. Gastroenterol. 40 (2005) 1140-1148
120. Tornblom H., Lang B., Clover L., Knowles C.H., Vincent A., and Lindberg G. Autoantibodies in patients with gut motility disorders and enteric neuropathy. Scand. J. Gastroenterol. 42 (2007) 1289-1293
121. Tornblom H., Lindberg G., Nyberg B., and Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 123 (2002) 1972-1979
122. Toyka K.V., Drachman D.B., Griffin D.E., Pestronk A., Winkelstein J.A., Fishbeck K.H., and Kao I. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N. Engl. J. Med. 296 (1977) 125-131
123. Tozzoli R. Recent advances in diagnostic technologies and their impact in autoimmune diseases. Autoimmun. Rev. 6 (2007) 334-340
124. Treacy W.L., Baggenstoss A.H., Slocumb C.H., and Code C.F. Scleroderma of the oesophagus. A correlation of histologic and physiologic findings. Ann. Intern. Med. 59 (1963) 351-356
125. Valenzuela D.M., Stitt T.N., DiStefano P.S., Rojas E., Mattsson K., Compton D.L., Nunez L., Park J.S., Stark J.L., Gies D.R., et al. Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury. Neuron 15 (1995) 573-584
126. Verne G.N., Hahn A.B., Pineau B.C., Hoffman B.J., Wojciechowski B.W., and Wu W.C. Association of HLA-DR and -DQ alleles with idiopathic achalasia. Gastroenterology 117 (1999) 26-31
127. Verne G.N., Sallustio J.E., and Eaker E.Y. Anti-myenteric neuronal antibodies in patients with achalasia. A prospective study. Dig. Dis. Sci. 42 (1997) 307-313
128. Vernino S., Adamski J., Kryzer T.J., Fealey R.D., and Lennon V.A. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 50 (1998) 1806-1813
129. Vernino S., Ermilov L.G., Sha L., Szurszewski J.H., Low P.A., and Lennon V.A. Passive transfer of autoimmune autonomic neuropathy to mice. J. Neurosci. 24 (2004) 7037-7042
130. Vernino S., Low P.A., Fealey R.D., Stewart J.D., Farrugia G., and Lennon V.A. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N. Engl. J. Med. 343 (2000) 847-855
131. Vernino S., Low P.A., and Lennon V.A. Experimental autoimmune autonomic neuropathy. J. Neurophysiol. 90 (2003) 2053-2059
132. Vianna-Jorge R., Oliveira C.F., Garcia M.L., Kaczorowski G.J., and Suarez-Kurtz G. Correolide, a nor-triterpenoid blocker of Shaker-type Kv1 channels elicits twitches in guinea-pig ileum by stimulating the enteric nervous system and enhancing neurotransmitter release. Br. J. Pharmacol. 131 (2000) 772-778
133. Vincent A. Measuring and evaluating the significance of autoantibodies in neurological disorders. Clin. Appl. Immunol. Rev. 3 (2002) 127-151
134. Vincent A., Lang B., and Kleopa K.A. Autoimmune channelopathies and related neurological disorders. Neuron 52 (2006) 123-138
135. Vincent A., and Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J. Neurol. Neurosurg. Psychiatry 48 (1985) 1246-1252
136. Vincent A., and Willcox N. The role of T-cells in the initiation of autoantibody responses in thymoma patients. Pathol. Res. Pract. 195 (1999) 535-540
137. Wang L.H., Fang X.C., and Pan G.Z. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 53 (2004) 1096-1101
138. Werth B., Meyer-Wyss B., Spinas G.A., Drewe J., and Beglinger C. Non-invasive assessment of gastrointestinal motility disorders in diabetic patients with and without cardiovascular signs of autonomic neuropathy. Gut 33 (1992) 1199-1203
139. Weusten B.L., and Smout A.J. Primary oesophageal motility disorders: how primary are they?. Eur. J. Gastroenterol. Hepatol. 11 (1999) 1345-1347
140. Wingate D., Hongo M., Kellow J., Lindberg G., and Smout A. Disorders of gastrointestinal motility: towards a new classification. J. Gastroenterol. Hepatol. 17 Suppl. (2002) S1-14